Skip to main content
Anna Pavlick, DO, Oncology, New York, NY, New York-Presbyterian Hospital

AnnaPavlickDOMBA

Oncology New York, NY

Hematologic Oncology, Melanoma

Professor of Medicine and Dermatology, Weill Cornell School of Medicine

Overview of Dr. Pavlick

Dr. Anna Pavlick is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Rowan University School of Osteopathic Medicine and has been in practice 27 years. Dr. Pavlick accepts several types of health insurance, listed below. She is one of 369 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
  • Hackensack University Medical Center
    Hackensack University Medical CenterResidency, Internal Medicine, 1990 - 1993
  • Rowan University School of Osteopathic Medicine
    Rowan University School of Osteopathic MedicineClass of 1990

Certifications & Licensure

  • NJ State Medical License
    NJ State License Current
  • NY State Medical License
    NY State License 1991 - 2025

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2009-2014
  • New York Magazine: Top Doctors Castle Connolly, 2011, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain  
    Kim Margolin, Omid Hamid, Christopher D Lao, Anna C Pavlick, Michael A Postow, F Stephen Hodi, Nikhil I Khushalani, Marc S Ernstoff, Hussein A Tawbi, Igor Puzanov, Ahm..., The New England Journal of Medicine

Lectures

  • A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients ... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Texas Nurse, 42, Scratches ‘Birthmark’ and Discovers It Was Actually Dangerous Skin Cancer — Understanding Racial Disparities in Cancer
    Texas Nurse, 42, Scratches ‘Birthmark’ and Discovers It Was Actually Dangerous Skin Cancer — Understanding Racial Disparities in CancerMay 4th, 2023
  • 3 Skin Cancer Myths, Busted: Can One Bad Sun Burn Cause Cancer?
    3 Skin Cancer Myths, Busted: Can One Bad Sun Burn Cause Cancer?April 23rd, 2023
  • Psychiatry Resident Doctor Who Went Viral for His Mental Health Advocacy Says He’s Cancer Free After Surgery for Melanoma; Understanding This Type of Skin Cancer
    Psychiatry Resident Doctor Who Went Viral for His Mental Health Advocacy Says He’s Cancer Free After Surgery for Melanoma; Understanding This Type of Skin CancerNovember 15th, 2021
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment